Mr Jeffrey Scott Fergerson, MPT | |
192 Tilley Dr, South Burlington, VT 05403-4440 | |
(802) 847-7115 | |
Not Available |
Full Name | Mr Jeffrey Scott Fergerson |
---|---|
Gender | Male |
Speciality | Physical Therapist |
Location | 192 Tilley Dr, South Burlington, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841397429 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 040.0003606 (Vermont) | Secondary |
225100000X | Physical Therapist | 040-0003606 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Jeffrey Scott Fergerson, MPT 192 Tilley Dr, South Burlington, VT 05403-4440 Ph: (802) 847-7115 | Mr Jeffrey Scott Fergerson, MPT 192 Tilley Dr, South Burlington, VT 05403-4440 Ph: (802) 847-7115 |
News Archive
Cross Country Healthcare, Inc. today announced the refinancing of its revolving loan credit facility and extension of the maturity date by approximately three years. The Company also elected to reduce the aggregate principal amount of the revolving credit facility to $50.0 million. The revolving credit facility was undrawn upon the closing of the refinancing.
A new study has shown that approximately 53 per cent of NHS patients displayed clinical symptoms of depression and anxiety within a year after completing psychological treatments.
Merck, known as MSD outside the United States and Canada, today announced Phase IIb data for MK-3102, the company's investigational once-weekly DPP-4 inhibitor in development for the treatment of type 2 diabetes.
A large study of children has uncovered evidence that behavioral problems in children who snore may be associated with changes in the structure of their brain's frontal lobe.
› Verified 3 days ago